Boston Scientific (BSX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY26 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| Boston Scientific (NYSE: BSX) | Delayed: 42.06 -0.37 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.43 | 52 Week High | $24.79 | |||
| Open | $41.81 | 52 Week Low | $15.67 | |||
| Day High | $43.04 | P/E | N/A | |||
| Day Low | $41.68 | EPS | $-0.09 | |||
| Volume | 19,321,589 | |||||
